Health Third Harmonic Bio Announces Third Quarter 2022 Financial Globe News Wire Nov 10, 2022 Successfully Completed Upsized Initial Public Offering Providing Funding Through 2025 Patient Dosing Underway in Phase 1b Chronic Inducible Urticaria Clinical Trial CAMBRIDGE, Mass., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Third Harmonic…